-transparent.png){kind=logo}
Effects of tolbutamide on the activity of hepatic phosphoenolpyruvate carboxykinase (PEPCK), a rate limiting enzyme in gluconeogenesis, was examined using rat hepatoma (H4IIE) cells. Tolbutamide inhibited PEPCK activity induced by cAMP in a time- and dose-dependent manner. Tolbutamide effect was rapidly exerted and insulin-independent. The inhibitory effect of 5 mM tolbutamide corresponded with that of 10(-7) M insulin. These results suggest the possibility that tolbutamide plays a significant role on amelioration of the deranged glucose metabolism in the liver through repression of gluconeogenesis, primarily due to the inhibition of PEPCK activity.
Related Publications
M Emoto, and
Y Inoue, and
K Kaku, and
T Kaneko
December 1986,
The Journal of biological chemistry,
M Emoto, and
Y Inoue, and
K Kaku, and
T Kaneko
February 1988,
Archives of biochemistry and biophysics,
M Emoto, and
Y Inoue, and
K Kaku, and
T Kaneko
September 2006,
Bioscience, biotechnology, and biochemistry,
M Emoto, and
Y Inoue, and
K Kaku, and
T Kaneko
August 1990,
The Journal of biological chemistry,
M Emoto, and
Y Inoue, and
K Kaku, and
T Kaneko
February 2002,
Biochemical and biophysical research communications,
M Emoto, and
Y Inoue, and
K Kaku, and
T Kaneko
July 2001,
Biochemical and biophysical research communications,
M Emoto, and
Y Inoue, and
K Kaku, and
T Kaneko
November 1992,
Somatic cell and molecular genetics,
M Emoto, and
Y Inoue, and
K Kaku, and
T Kaneko
October 1972,
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
M Emoto, and
Y Inoue, and
K Kaku, and
T Kaneko
January 2000,
FEBS letters,
M Emoto, and
Y Inoue, and
K Kaku, and
T Kaneko
August 1994,
The American journal of physiology,
